Get Premium to unlock powerful stock data

Vivo Capital, LLC Buys Ventyx Biosciences Inc, Relmada Therapeutics Inc, IO Biotech Inc, Sells Ascendis Pharma A/S, , Legend Biotech Corp

Author's Avatar
Feb 18, 2022
Article's Main Image
Investment company Vivo Capital, LLC (Current Portfolio) buys Ventyx Biosciences Inc, Relmada Therapeutics Inc, IO Biotech Inc, Minerva Surgical Inc, BELLUS Health Inc, sells Ascendis Pharma A/S, , Legend Biotech Corp, Curis Inc, Aurinia Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Vivo Capital, LLC. As of 2021Q4, Vivo Capital, LLC owns 55 stocks with a total value of $1.7 billion. These are the details of the buys and sells.

For the details of Vivo Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/vivo+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Vivo Capital, LLC
  1. Instil Bio Inc (TIL) - 12,486,787 shares, 12.88% of the total portfolio.
  2. Harmony Biosciences Holdings Inc (HRMY) - 4,884,341 shares, 12.56% of the total portfolio.
  3. New Frontier Health Corp (NFH) - 14,300,000 shares, 9.88% of the total portfolio.
  4. IVERIC bio Inc (ISEE) - 6,290,827 shares, 6.34% of the total portfolio. Shares added by 5.44%
  5. ALX Oncology Holdings Inc (ALXO) - 4,220,048 shares, 5.47% of the total portfolio.
New Purchase: Ventyx Biosciences Inc (VTYX)

Vivo Capital, LLC initiated holding in Ventyx Biosciences Inc. The purchase prices were between $14.2 and $23.07, with an estimated average price of $18.94. The stock is now traded at around $10.280000. The impact to a portfolio due to this purchase was 2.15%. The holding were 1,791,275 shares as of 2021-12-31.

New Purchase: Relmada Therapeutics Inc (RLMD)

Vivo Capital, LLC initiated holding in Relmada Therapeutics Inc. The purchase prices were between $16.93 and $26.82, with an estimated average price of $22.13. The stock is now traded at around $18.280000. The impact to a portfolio due to this purchase was 1.2%. The holding were 882,352 shares as of 2021-12-31.

New Purchase: IO Biotech Inc (IOBT)

Vivo Capital, LLC initiated holding in IO Biotech Inc. The purchase prices were between $6.4 and $15.65, with an estimated average price of $9.57. The stock is now traded at around $8.468000. The impact to a portfolio due to this purchase was 1.16%. The holding were 3,015,545 shares as of 2021-12-31.

New Purchase: Minerva Surgical Inc (UTRS)

Vivo Capital, LLC initiated holding in Minerva Surgical Inc. The purchase prices were between $4.53 and $9.78, with an estimated average price of $7.11. The stock is now traded at around $5.260000. The impact to a portfolio due to this purchase was 0.69%. The holding were 2,215,667 shares as of 2021-12-31.

New Purchase: BELLUS Health Inc (BLU)

Vivo Capital, LLC initiated holding in BELLUS Health Inc. The purchase prices were between $5.26 and $8.3, with an estimated average price of $6.65. The stock is now traded at around $7.035000. The impact to a portfolio due to this purchase was 0.49%. The holding were 1,017,152 shares as of 2021-12-31.

New Purchase: Compass Therapeutics Inc (CMPX)

Vivo Capital, LLC initiated holding in Compass Therapeutics Inc. The purchase prices were between $2.88 and $4.08, with an estimated average price of $3.56. The stock is now traded at around $2.350000. The impact to a portfolio due to this purchase was 0.38%. The holding were 2,000,000 shares as of 2021-12-31.

Added: Cogent Biosciences Inc (COGT)

Vivo Capital, LLC added to a holding in Cogent Biosciences Inc by 35.19%. The purchase prices were between $7.51 and $10.81, with an estimated average price of $8.7. The stock is now traded at around $6.060000. The impact to a portfolio due to this purchase was 0.26%. The holding were 1,920,941 shares as of 2021-12-31.

Added: Olema Pharmaceuticals inc (OLMA)

Vivo Capital, LLC added to a holding in Olema Pharmaceuticals inc by 36.41%. The purchase prices were between $8.75 and $30.71, with an estimated average price of $20.45. The stock is now traded at around $4.650000. The impact to a portfolio due to this purchase was 0.25%. The holding were 1,689,515 shares as of 2021-12-31.

Sold Out: (KDMN)

Vivo Capital, LLC sold out a holding in . The sale prices were between $8.54 and $9.5, with an estimated average price of $9.15.

Sold Out: Curis Inc (CRIS)

Vivo Capital, LLC sold out a holding in Curis Inc. The sale prices were between $4.45 and $8.09, with an estimated average price of $5.89.

Sold Out: Aurinia Pharmaceuticals Inc (AUPH)

Vivo Capital, LLC sold out a holding in Aurinia Pharmaceuticals Inc. The sale prices were between $17.78 and $33.08, with an estimated average price of $23.65.

Sold Out: Crinetics Pharmaceuticals Inc (CRNX)

Vivo Capital, LLC sold out a holding in Crinetics Pharmaceuticals Inc. The sale prices were between $19.35 and $28.41, with an estimated average price of $24.78.

Sold Out: Arcutis Biotherapeutics Inc (ARQT)

Vivo Capital, LLC sold out a holding in Arcutis Biotherapeutics Inc. The sale prices were between $14.98 and $25.5, with an estimated average price of $19.79.

Sold Out: Kura Oncology Inc (KURA)

Vivo Capital, LLC sold out a holding in Kura Oncology Inc. The sale prices were between $12.22 and $19.57, with an estimated average price of $16.12.



Here is the complete portfolio of Vivo Capital, LLC. Also check out:

1. Vivo Capital, LLC's Undervalued Stocks
2. Vivo Capital, LLC's Top Growth Companies, and
3. Vivo Capital, LLC's High Yield stocks
4. Stocks that Vivo Capital, LLC keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles